Drug Type Biosimilar, Monoclonal antibody |
Synonyms Dupilumab Biosimilar (Prestige BioPharma Ltd.), IDC 2501, IDC-2501 + [1] |
Target |
Action inhibitors |
Mechanism IL-4Rα inhibitors(Interleukin-4 receptor subunit alpha inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |


| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Skin Diseases | Discovery | Singapore | 01 Jul 2025 |






